Harold E. “barry†Selick
Chairman
Immunology
Protagonist Therapeutics
Australia
Biography
Dr. Selick has served on our board of directors since February 2009. Dr. Selick is Vice Chancellor for Business Development, Innovation and Partnerships at University of California San Francisco. He also serves as Chairman of Molecular Templates effective August 2017. He served as CEO of Threshold Pharmaceuticals from June 2002 to April 2017, which recently merged with Molecular Templates. From June 2002 until July 2007, Dr. Selick was also a Venture Partner of Sofinnova Ventures, Inc., a venture capital firm.
Research Interest
Immunology
